|
Literature / Source Database:
EBioMedicine
Description
EBioMedicine is the leading open access forum for connecting basic and clinical biomedical researchers. The journal is published in collaboration with Cell Press and The Lancet.
| Title (short) |
EBioMedicine |
| Languages |
English |
| First year |
2014 |
| Editor |
Julie Stacey; Duc H Le |
|
|
|
Status
active
Indexing
Journal Citation Reports - Science Edition; Science Citation Index Expanded; EMBASE; Directory of Open Access Journals (DOAJ); MEDLINE®; PubMed Central; ScienceDirect; Scopus
Source type
Journal
Publisher
E ISSN
2352-3964
First volume
1
Last volume
30+
Publish city
Amsterdam
Homepage
| Resources |
|
Availability |
|
|
|
|
|
| Text PDF |
 |
free access |
|
| Text Html |
 |
for subscriber |
 |
| References |
|
not available |
|
| Abstracts |
|
|
|
| TOC |
|
|
|
|
|
|
|
Description
The effective translation of insights gained from biomedical research into improved human health is a global priority. To this end, Elsevier has looked to the leadership of its two leading brands, Cell Press and The Lancet, to guide the launch of a new comprehensive, online-only open access Elsevier journal, EBioMedicine, focused on forming a community that spans this interface and creates a valuable opportunity for dialogue and collaboration between their respective audiences.
As the communities that border this interface are large and diverse, the scope of EBioMedicine will cover the entire breadth of translational and clinical research within all disciplines of life and health sciences, ranging from basic science to clinical and public/global health science. The journal will also place a high priority on rapid publication. The journal seeks to publish a broad range of research study types, from experimental findings, critical analyses, methodological & technical innovations, and hypotheses to observational epidemiological studies, clinical trials, meta-analyses, and study protocols. In addition, EBioMedicine will publish commentaries, reviews, and viewpoints that enhance the accessibility and applicability of basic research findings for health professionals, and promote a better understanding of clinical challenges for biomedical researchers.
In leveraging the editorial leadership from Cell Press and The Lancet together with the publishing expertise of Elsevier to create a unique forum for the reputable and speedy publication of research in life and health sciences, we are committed to facilitating and incentivizing a robust and successful pipeline for improved human health globally.
|
